← ANALYST RATINGS · TIPRANKS
HeartFlow, Inc. (HTFL): analyst forecast and price target
Analyst consensus
Strong Buy8 Buy2 Hold0 Sell
Ratings of 10 analysts in the last 3 months12-month forecast
Based on 10 price targets given in the last 3 months, the average target is $44.78, the highest $56.00, the lowest $34.00. The average is −7.3% from the last price of $48.29.
Analyst ratings 10
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Healthcare Information ServicesxAI Grok-3 | TipRanks - xAI | $52.00 | Hold | +7.7% | Reiterated | 23.09.26on TipRanks 15:05 | — | |
| AI DeepSeek Medical - Healthcare Information ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $54.00 | Hold | +11.8% | Reiterated | 23.09.26on TipRanks 15:05 | — | |
| AI OpenAI Medical - Healthcare Information ServicesOpenAI 5.2 | TipRanks - OpenAI | $53.00 | Hold | +9.8% | Reiterated | 23.09.26on TipRanks 15:05 | — | |
| AI Anthropic Medical - Healthcare Information ServicesAnthropic Opus-4.5 | TipRanks - Anthropic | $53.00 | Hold | +9.8% | Reiterated | 23.09.26on TipRanks 15:05 | — | |
| AI Google Medical - Healthcare Information ServicesGemini 3-pro | TipRanks - Google | $55.00 | Hold | +13.9% | Reiterated | 23.09.26on TipRanks 15:05 | — | |
| AI PerPlexity Medical - Healthcare Information ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $53.00 | Hold | +9.8% | Reiterated | 23.09.26on TipRanks 15:05 | — | |
| William Plovanic★★★★★★★★★★#5377 · hits 43% · avg +1.3% | Canaccord Genuity | $45.00 → $56.00+24.4% | Buy | +16.0% | Reiterated | 22.09.26on TipRanks 06:50 | −0.3%next day −4.8% · 5 days +0.5% | ↗ |
| Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% | William Blair | — | Buy | — | Reiterated | 11.09.26on TipRanks 12:45 | +8.8%next day −0.2% · 5 days +1.8% | ↗ |
| Unknown Analyst | UBS | $55.00 | Hold | +13.9% | Initiated | 08.09.26on TipRanks Sep 11 12:45 | −1.8%next day −1.8% · 5 days +2.3% | ↗ |
| Eugene Mannheimer★★★★★★★★★★#3417 · hits 51% · avg +6.8% | Freedom Capital Markets | $37.00 → $44.00+18.9% | Buy | −8.9% | Reiterated | 27.08.26on TipRanks Sep 27 04:50 | −2.4%next day −0.4% · 5 days +3.1% | ↗ |
| Kallum Titchmarsh★★★★★★★★★★#2647 · hits 58% · avg +9.6% | Morgan Stanley | $35.00 → $40.00+14.3% | Hold | −17.2% | Reiterated | 17.08.26on TipRanks Aug 14 08:35 | +35.9%next day +0.1% · 5 days +19.6% | ↗ |
| Matthew O'Brien★★★★★★★★★★#12031 · hits 41% · avg −4.5% | Piper Sandler | $38.00 → $45.00+18.4% | Buy | −6.8% | Reiterated | 14.08.26on TipRanks 08:20 | +35.9%next day +0.1% · 5 days +19.6% | ↗ |
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | $35.00 → $45.00+28.6% | Buy | −6.8% | Reiterated | 14.08.26on TipRanks 07:55 | +35.9%next day +0.1% · 5 days +19.6% | ↗ |
| Rick Wise★★★★★★★★★★#7800 · hits 51% · avg +0.1% | Stifel Nicolaus | $40.00 → $45.00+12.5% | Buy | −6.8% | Reiterated | 14.08.26on TipRanks 07:30 | +35.9%next day +0.1% · 5 days +19.6% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $37.00 → $39.00+5.4% | Buy | −19.2% | Assigned | 14.08.26on TipRanks 06:55 | +35.9%next day +0.1% · 5 days +19.6% | ↗ |
| David Rescott★★★★★★★★★★#3448 · hits 49% · avg +5.1% | Robert W. Baird | $34.00 | Buy | −29.6% | Initiated | 30.07.26on TipRanks Jul 31 05:09 | +1.5%next day −3.0% · 5 days +1.6% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering HeartFlow, Inc.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $44.78 at a price of $49.75 (−10.0%); now: $44.78 at $48.29 (−7.3%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 2 | 0 | 0 | 0 | 0 |
| Buy | 9 | 8 | 11 | 13 | 12 | 9 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 18.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.10 (from $-0.14 to $-0.08). Last quarter: $-0.07.
Sales
Next quarter’s sales estimate — $65M (from $65M to $66M). Last quarter: $64M.
Best top-analyst consensus in the sector · General
About HeartFlow, Inc.
- CEO: John Farquhar
- Employees: 843
- 135 Main Street, San Francisco, CA, 94105, US
- www.heartflow.com
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Data from the stock’s TipRanks forecast page, read 93 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗